Posted by psychobot5000 on June 8, 2007, at 23:44:52
In reply to Re: Saredutant » Rosie123, posted by Phillipa on June 8, 2007, at 21:51:00
Saredutant's an experimental medication, one of the more exciting ones in the pipeline for depression and anxiety.
____
"NK1 receptor antagonist
From Wikipedia, the free encyclopedia
Neurokinin NK1 antagonists are a novel class of medications that possesses unique antidepressant[1], anxiolytic[2], and antiemetic properties.The NK2 and NK3 receptors are also targets for novel classes of medications, and also show prominent antidepressive and anxiolytic effects.[3]"
_____________________________________Saredutant, I believe, is supposed to be an NK2 antagonist, and is in Phase III trials. Mostly, you can never know for certain the safety of an experimental medication, but it sounds like a very interesting opportunity. I believe this class of meds are considered promising. They have a new mechanism of action, as compared to everything that's been used for the past five decades.
poster:psychobot5000
thread:761880
URL: http://www.dr-bob.org/babble/20070604/msgs/761949.html